STRO

Sutro Biopharma (STRO)

Sutro Biopharma Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:STRO

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/11	05 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STRO	Sutro Biopharma Inc
2024/06/11	05 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:STRO	Sutro Biopharma Inc
2024/06/11	05 : 24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STRO	Sutro Biopharma Inc
2024/06/11	05 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STRO	Sutro Biopharma Inc
2024/06/11	05 : 19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STRO	Sutro Biopharma Inc
2024/05/18	06 : 00	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:STRO	Sutro Biopharma Inc
2024/05/14	05 : 34	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:STRO	Sutro Biopharma Inc
2024/05/14	05 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:STRO	Sutro Biopharma Inc
2024/05/14	05 : 30	GlobeNewswire Inc.	Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones	NASDAQ:STRO	Sutro Biopharma Inc
2024/04/30	21 : 00	GlobeNewswire Inc.	Sutro Biopharma Announces Initiation of Randomized Portion (Part 2) of REFRαME-O1 Trial	NASDAQ:STRO	Sutro Biopharma Inc
2024/04/02	19 : 18	GlobeNewswire Inc.	Sutro Biopharma Announces Pricing of $75 Million Underwritten Offering	NASDAQ:STRO	Sutro Biopharma Inc
2024/03/26	05 : 30	GlobeNewswire Inc.	Sutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated Milestones	NASDAQ:STRO	Sutro Biopharma Inc
2024/03/08	06 : 32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STRO	Sutro Biopharma Inc
2024/03/08	06 : 28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STRO	Sutro Biopharma Inc
2024/03/08	06 : 26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STRO	Sutro Biopharma Inc
2024/03/08	06 : 24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STRO	Sutro Biopharma Inc
2024/03/06	06 : 45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STRO	Sutro Biopharma Inc
2024/03/06	06 : 32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STRO	Sutro Biopharma Inc
2024/03/05	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STRO	Sutro Biopharma Inc
2024/02/28	06 : 33	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:STRO	Sutro Biopharma Inc
2024/02/14	02 : 16	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:STRO	Sutro Biopharma Inc
2024/02/12	20 : 06	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:STRO	Sutro Biopharma Inc
2024/02/10	06 : 27	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:STRO	Sutro Biopharma Inc
2024/02/10	06 : 25	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:STRO	Sutro Biopharma Inc
2024/02/07	06 : 05	GlobeNewswire Inc.	Sutro Biopharma to Participate in Upcoming Investor Conferences	NASDAQ:STRO	Sutro Biopharma Inc
2024/02/01	06 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STRO	Sutro Biopharma Inc
2024/01/30	07 : 14	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:STRO	Sutro Biopharma Inc
2024/01/08	21 : 31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:STRO	Sutro Biopharma Inc
2024/01/05	06 : 05	GlobeNewswire Inc.	Sutro Biopharma Highlights Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeting ADC	NASDAQ:STRO	Sutro Biopharma Inc
2023/12/15	06 : 05	GlobeNewswire Inc.	Sutro Biopharma to Host Investor Webcast Highlighting Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeted ADC, on January 4, 2024	NASDAQ:STRO	Sutro Biopharma Inc